Shingo Nakayamada

24PUBLICATIONS
72CO-AUTHORS
Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityRegenerative medicine (incl. stem cells)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 17, 2026
Treatment persistence and clinical outcomes following subcutaneous methotrexate initiation in patients with rheumatoid arthritis: a real-world observational study.

|Sep 25, 2026
Clinical and immunological outcomes of rituximab-based, mycophenolate mofetil-based and cyclophosphamide-based treatment strategies for systemic lupus erythematosus with active kidney involvement from LOOPS registry.

|Aug 31, 2026
Emerging treatment strategies in systemic lupus erythematosus: integrating molecular stratification, targeted therapy, and treatment response evaluation.

|Aug 27, 2026
Rapid versus conventional glucocorticoid tapering in pure membranous LN: a multicentre retrospective study.

|Aug 19, 2026
Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study.

|Jul 29, 2026
Association of glycation gap with hypoglycemia CGM indices, diabetic complications, and quality of life in Japanese type 2 diabetes patients.

Pageof 4

Frequent Collaborators

19 joint publications

Yoshiya Tanaka

9 joint publications

Satoshi Kubo

6 joint publications

Masanobu Ueno

6 joint publications

Yuya Fujita